p14ARF links the tumour suppressors RB and p53 - PubMed (original) (raw)

. 1998 Sep 10;395(6698):124-5.

doi: 10.1038/25867.

• PMID: 9744267
• DOI: 10.1038/25867

p14ARF links the tumour suppressors RB and p53

S Bates et al. Nature. 1998.

No abstract available

PubMed Disclaimer

Similar articles

• E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation.
  Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. Nip J, et al. Oncogene. 2001 Feb 22;20(8):910-20. doi: 10.1038/sj.onc.1204171. Oncogene. 2001. PMID: 11314026
• DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
  Raveh T, Droguett G, Horwitz MS, DePinho RA, Kimchi A. Raveh T, et al. Nat Cell Biol. 2001 Jan;3(1):1-7. doi: 10.1038/35050500. Nat Cell Biol. 2001. PMID: 11146619
• Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
  Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP. Gewirtz DA, et al. Arch Biochem Biophys. 2001 Apr 15;388(2):243-52. doi: 10.1006/abbi.2000.2278. Arch Biochem Biophys. 2001. PMID: 11368161
• The cell cycle-regulating transcription factors E2F-RB.
  Brehm A, Miska E, Reid J, Bannister A, Kouzarides T. Brehm A, et al. Br J Cancer. 1999 Jul;80 Suppl 1:38-41. Br J Cancer. 1999. PMID: 10466760 Review. No abstract available.
• [Cell growth control by the E2F transcription factor].
  Ohtani K, Ikeda M. Ohtani K, et al. Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1603-11. Tanpakushitsu Kakusan Koso. 1997. PMID: 9279087 Review. Japanese. No abstract available.

Cited by

• The Construction of a Multi-Gene Risk Model for Colon Cancer Prognosis and Drug Treatments Prediction.
  Gao L, Tian Y, Chen E. Gao L, et al. Int J Mol Sci. 2024 Apr 2;25(7):3954. doi: 10.3390/ijms25073954. Int J Mol Sci. 2024. PMID: 38612764 Free PMC article.
• ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework.
  Timofeev O, Giron P, Lawo S, Pichler M, Noeparast M. Timofeev O, et al. NPJ Precis Oncol. 2024 Mar 14;8(1):70. doi: 10.1038/s41698-024-00554-5. NPJ Precis Oncol. 2024. PMID: 38485987 Free PMC article. Review.
• PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.
  Palanivel C, Madduri LSV, Hein AL, Jenkins CB, Graff BT, Camero AL, Zhou S, Enke CA, Ouellette MM, Yan Y. Palanivel C, et al. Aging (Albany NY). 2024 Mar 4;16(5):4116-4137. doi: 10.18632/aging.205619. Epub 2024 Mar 4. Aging (Albany NY). 2024. PMID: 38441530 Free PMC article.
• Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.
  Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Zhao L, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Zhou Y, et al. Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511. Biology (Basel). 2023. PMID: 38132337 Free PMC article. Review.
• The Pathology according to p53 Pathway.
  Hatano Y. Hatano Y. Pathobiology. 2024;91(3):230-243. doi: 10.1159/000535203. Epub 2023 Nov 14. Pathobiology. 2024. PMID: 37963443 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal